Thu, Mar 05, 2026 | Updated 04:31 IST
Feb 11, 2025
New York [US]/ London [UK]/ Munich [Germany]/ New Delhi [India], February 11: Datar Cancer Genetics (DCG), a global leader in non-invasive cancer diagnostics, announces Dr. Massimo Cristofanilli as Strategic Advisor, reinforcing its commitment to advancing early cancer detection and precision treatment. Dr. Cristofanilli, an expert in circulating tumor cells, biomarkers, and molecular profiling, will collaborate with DCG to develop innovative solutions for early and accurate cancer detection and treatment personalization.
He said, "By end of calendar 26 the entire country would be working only on 5G. We have already started developing our indigenous technology for 6G for telecom connectivity."
More News
Mumbai (Maharashtra) [India], February 11: Mahindra Electric launched its BE6 and XEV9E at Hare Krishan Mahindra, an authorized...
Bengaluru (Karnataka) [India], February 11: Acuity Knowledge Partners (Acuity), a leading provider of bespoke research, analytics, talent and...
Union Minister for Petroleum and Natural Gas, Hardeep Singh Puri, on Tuesday emphasized that oil and gas will...